Vitamin D için Inflammatory Bowel Disease (IBD) — General
BSupplementation (1,000-4,000 IU/day) reduces relapse risk in both UC and Crohn's. Deficiency is common in IBD (up to 60%) and correlates with disease severity.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dinflammatory\u002Dbowel\u002Ddisease';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
Sonuç
Supplementation (1,000-4,000 IU/day) reduces relapse risk in both UC and Crohn's. Deficiency is common in IBD (up to 60%) and correlates with disease severity.
Key Study Findings
Review
Early Evidence Indicates Vitamin D Improves Symptoms of Irritable Bowel Syndrome: Nursing Implications and Future …
Dose: None
vs: None
Outcome: IBS symptom improvement with vitamin D supplementation
Etki: None
None
Popülasyon: individuals with irritable bowel syndrome
Review
Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment.
Dose: None
vs: None
Outcome: None
Etki: None
None
Popülasyon: patients with ulcerative colitis
Review
Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects.
Dose: None
vs: None
Outcome: None
Etki: None
None
Popülasyon: review of probiotics as therapeutic strategy for inflammatory bowel disease
Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None
vs: None
Outcome: Micronutrient deficiency management in pediatric IBD
Etki: None
None
Popülasyon: Children with inflammatory bowel disease (review)
Observational Study
n=193
The importance of vitamin D levels in patients with inflammatory bowel disease.
Dose: None
vs: Clinical activity groups and VD status groups
Outcome: Vitamin D levels and IBD activity markers
Etki: None
0.009 (CD), 0.033 (UC), 0.032
Popülasyon: Greek IBD patients (122 CD, 71 UC)
Review
Osteoporosis: A Review.
Dose: None
vs: None
Outcome: None
Etki: None
None
Popülasyon: Adults with osteoporosis
Key Statistics
10
Çalışmalar
1500
Katılımcılar
↑
Positive
B
Derece
Referenced Papers
Gastroenterology nursing : …
None
4 atıf
Digestive diseases and …
2026
1 atıf
Trends in molecular …
2025
35 atıf
Arquivos de neuro-psiquiatria
2025
6 atıf
Nutrients
2025
4 atıf
Journal of physiology …
2025
3 atıf
The American journal …
2025
CCL20 expression is elevated in inflammatory bowel disease and attenuated by vitamin D metabolites.
Other
Scientific reports
2025
Osteoporosis: A Review.
Review
JAMA
2025
Nutrients
2024
47 atıf
Nutrients
2024
27 atıf
Swiss medical weekly
2024
9 atıf
Nutricion hospitalaria
2024
2 atıf
Asia Pacific journal …
2024
1 atıf
Paediatrics and international …
2023
48 atıf
The American journal …
2023
37 atıf
Vitamin D therapy in pediatric patients with inflammatory bowel disease: a systematic review and meta-analysis.
Meta-Analysis
World journal of …
2023
11 atıf
Frontiers in pediatrics
2023
6 atıf
JGH open : …
2023
5 atıf
Toxicology mechanisms and …
2023
5 atıf
Archives of Iranian …
2023
2 atıf
Vitamin D for the treatment of inflammatory bowel disease.
Systematic Review
The Cochrane database …
2023
1 atıf
Endocrine connections
2022
50 atıf
Journal of inflammation …
2022
50 atıf
Autoimmunity reviews
2022
44 atıf
Frontiers in bioscience …
2022
17 atıf
PloS one
2022
10 atıf
Medwave
2022
4 atıf
European journal of …
2021
40 atıf
Effects of oral vitamin D supplementation on inflammatory bowel disease: a systematic review and meta-analysis.
Meta-Analysis
Food & function
2021
25 atıf
Vitamin D Supplementation and Mental Health in Inflammatory Bowel Diseases and Irritable Bowel Syndrome Patients: A Systematic Review.
Systematic Review
Nutrients
2021
16 atıf
Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Meta-Analysis
Inflammatory bowel diseases
2020
57 atıf
Autoimmunity reviews
2020
48 atıf
Acta biochimica Polonica
2020
10 atıf
The Korean journal …
2020
3 atıf
Revista espanola de …
2020
2 atıf
Nutrients
2019
193 atıf
Frontline gastroenterology
2019
58 atıf
Critical reviews in …
2019
45 atıf
Complementary therapies in …
2019
27 atıf
Current drug metabolism
2019
7 atıf
Current opinion in …
2019
5 atıf
Current opinion in …
2018
94 atıf
Gastroenterology clinics of …
2018
67 atıf
Journal of research …
2018
48 atıf
Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: what do we know and what …
Systematic Review
European journal of …
2018
39 atıf
Gastroenterology
2017
335 atıf
Fat-soluble Vitamin Deficiencies and Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Meta-Analysis
Journal of clinical …
2017
73 atıf
Nutrition in clinical …
2017
55 atıf
PloS one
2017
38 atıf
Control of Inflammatory Bowel Disease and Colorectal Cancer by Synthetic Vitamin D Receptor Ligands.
Review
Current medicinal chemistry
2017
14 atıf
Clinical gastroenterology and …
2017
8 atıf
Ugeskrift for laeger
2017
World journal of …
2016
238 atıf
World journal of …
2016
122 atıf
Iron Deficiency, Zinc, Magnesium, Vitamin Deficiencies in Crohn's Disease: Substitute or Not?
Review
Digestive diseases (Basel, …
2016
41 atıf
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis.
Review
Current pharmaceutical design
2016
32 atıf
Current gastroenterology reports
2016
22 atıf
Journal of medicinal …
2016
17 atıf
Gastroenterology & hepatology
2016
7 atıf
Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis.
Meta-Analysis
Inflammatory bowel diseases
2015
214 atıf
BioMed research international
2015
149 atıf
World journal of …
2015
62 atıf
The Proceedings of …
2015
46 atıf
Healthcare (Basel, Switzerland)
2015
7 atıf
Journal of inflammation …
2014
411 atıf
Experimental biology and …
2014
131 atıf
World journal of …
2014
117 atıf
Vitamin and zinc status pretreatment and posttreatment in patients with inflammatory bowel disease.
Other
Journal of pediatric …
2014
38 atıf
Inflammatory bowel diseases
2012
224 atıf
Alimentary pharmacology & …
2012
111 atıf
Current drug metabolism
2012
28 atıf
Vitamins and hormones
2011
25 atıf
Current opinion in …
2011
23 atıf
Vitamin D and inflammation.
Review
Joint bone spine
2010
281 atıf
Acta medica Indonesiana
2007
4 atıf
Nature clinical practice. …
2005
191 atıf
Alimentary pharmacology & …
2003
179 atıf
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Yaygın Kullanılan Dozajlar
- general:
- 600-800 IU/day (RDA)
- ibdsupport:
- 1,000-4,000 IU/day (target serum 25(OH)D >30 ng/mL)
- deficiencycorrection:
- 50,000 IU/week for 8 weeks, then 1,000-4,000 IU/day maintenance
Üst sınır: 4,000 IU/day (100 mcg); higher doses under medical supervision only
Araştırmalarda İncelenen Dozajlar
| Dozaj | Süre | Etki | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Neutral | -- |
| None | -- | Negative | 193 |
| None | -- | Mixed | -- |
| None | 690 weeks | Neutral | 357656 |
| None | -- | Positive | 310 |
En iyi alım zamanı: With a meal containing fat for better absorption
Safety & Side Effects
Bildirilen Yan Etkiler
- ⚠ Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion)
- ⚠ Kidney stones with excessive long-term supplementation
- ⚠ Constipation
- ⚠ Metallic taste
Bilinen Etkileşimler
- ● Thiazide diuretics (may increase risk of hypercalcemia)
- ● Corticosteroids (reduce vitamin D absorption and metabolism)
- ● Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
- ● Statins (vitamin D may affect statin metabolism)
Tolere edilebilir üst alım: 4,000 IU/day (100 mcg); higher doses under medical supervision only
Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.
Frequently Asked Questions
Does Vitamin D help with Inflammatory Bowel Disease (IBD) — General?
Based on 10 studies with 1,500 participants, there is moderate evidence from clinical studies that Vitamin D may support Inflammatory Bowel Disease (IBD) — General management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Inflammatory Bowel Disease (IBD) — General?
Studies have used various dosages. A commonly studied range is 600-800 IU/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion), Kidney stones with excessive long-term supplementation, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Inflammatory Bowel Disease (IBD) — General?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 1,500 total participants. The overall direction of effect is positive.
Related Evidence
Şu durum için diğer içerikler: Inflammatory Bowel Disease (IBD) — General
Vitamin D diğer sağlık durumları için
FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.